ADA

ADA Conference Content

featured article image

Automated Insulin Delivery System Shows Promise in Very Young Children with Type 1 Diabetes

author

Christos Evangelou, MSc, PhD

Jun 30, 2025

Read Stem Cell-Derived Islet Therapy Shows Promise for Type 1 Diabetes Treatmentarticle image
Christos Evangelou, MSc, PhD Link to Christos Evangelou, MSc, PhD's page

Stem Cell-Derived Islet Therapy Shows Promise for Type 1 Diabetes Treatment

Christos Evangelou, MSc, PhD

Jun 30, 2025 Link to Stem Cell-Derived Islet Therapy Shows Promise for Type 1 Diabetes Treatment

Read Oral Semaglutide Shows Greater Heart Benefits in Patients with Higher Blood Sugar Levelsarticle image
Christos Evangelou, MSc, PhD Link to Christos Evangelou, MSc, PhD's page

Oral Semaglutide Shows Greater Heart Benefits in Patients with Higher Blood Sugar Levels

Christos Evangelou, MSc, PhD

Jun 30, 2025 Link to Oral Semaglutide Shows Greater Heart Benefits in Patients with Higher Blood Sugar Levels

Read ADA 2025: A Landmark Gathering for Diabetes Innovation and Advocacyarticle image
Nuzhat (Kisat) Chalisa, MD, FACE, DABOM Link to Nuzhat (Kisat) Chalisa, MD, FACE, DABOM's page

ADA 2025: A Landmark Gathering for Diabetes Innovation and Advocacy

Nuzhat (Kisat) Chalisa, MD, FACE, DABOM

Jun 30, 2025 Link to ADA 2025: A Landmark Gathering for Diabetes Innovation and Advocacy

Read Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Focus: Why Every Diabetes Provider Needs to Be a Liver Health Champion in 2025article image
Melina Manolas, MD Link to Melina Manolas, MD's page

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Focus: Why Every Diabetes Provider Needs to Be a Liver Health Champion in 2025

Melina Manolas, MD

Jun 30, 2025 Link to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Focus: Why Every Diabetes Provider Needs to Be a Liver Health Champion in 2025

Read Adjunct Therapies to Insulin in People with Type 1 Diabetesarticle image
William Benjamin Horton, MD, FACP Link to William Benjamin Horton, MD, FACP's page

Adjunct Therapies to Insulin in People with Type 1 Diabetes

William Benjamin Horton, MD, FACP

Jun 30, 2025 Link to Adjunct Therapies to Insulin in People with Type 1 Diabetes

Read A Preview of Over-the-Counter Continuous Glucose Monitoring—Data for All or a Disaster Waiting to Happen?article image
Diana Isaacs, PharmD Link to Diana Isaacs, PharmD's page

A Preview of Over-the-Counter Continuous Glucose Monitoring—Data for All or a Disaster Waiting to Happen?

Diana Isaacs, PharmD

Jun 9, 2025 Link to A Preview of Over-the-Counter Continuous Glucose Monitoring—Data for All or a Disaster Waiting to Happen?

Read Future of Diabetes Management: Interconnected Chronic Disease Care at ADA 2024article image
Shubham Agarwal, MD Link to Shubham Agarwal, MD's page

Future of Diabetes Management: Interconnected Chronic Disease Care at ADA 2024

Shubham Agarwal, MD

Jul 1, 2024 Link to Future of Diabetes Management: Interconnected Chronic Disease Care at ADA 2024

Read Prioritization of GLP1-RA and Dual Agonists in an Era of Shortagesarticle image
Sara Jane Cromer, MD Link to Sara Jane Cromer, MD's page

Prioritization of GLP1-RA and Dual Agonists in an Era of Shortages

Sara Jane Cromer, MD

Jul 1, 2024 Link to Prioritization of GLP1-RA and Dual Agonists in an Era of Shortages

Read Tirzepatide - A New Dawn in Treating Obstructive Sleep Apnea and Obesity: Insights from the SURMOUNT-OSA Trial, ADA 2024article image
Priyanka Majety, MD Link to Priyanka Majety, MD's page

Tirzepatide - A New Dawn in Treating Obstructive Sleep Apnea and Obesity: Insights from the SURMOUNT-OSA Trial, ADA 2024

Priyanka Majety, MD

Jul 1, 2024 Link to Tirzepatide - A New Dawn in Treating Obstructive Sleep Apnea and Obesity: Insights from the SURMOUNT-OSA Trial, ADA 2024

Read Facts, Fiction, and Myths Around GLP-1s Discussed at the ADA Scientific Sessionsarticle image
Amber Healy, DO Link to Amber Healy, DO's page

Facts, Fiction, and Myths Around GLP-1s Discussed at the ADA Scientific Sessions

Amber Healy, DO

Jul 1, 2024 Link to Facts, Fiction, and Myths Around GLP-1s Discussed at the ADA Scientific Sessions

Read GLP-1 RAs: Beyond Glycemic Control to Cardiovascular, Renal, and Liver Benefitsarticle image
Byron J Hoogwerf, MD Link to Byron J Hoogwerf, MD's page

GLP-1 RAs: Beyond Glycemic Control to Cardiovascular, Renal, and Liver Benefits

Byron J Hoogwerf, MD

Jul 1, 2024 Link to GLP-1 RAs: Beyond Glycemic Control to Cardiovascular, Renal, and Liver Benefits

Read GLP-1 in the Spotlight: Key Takeaways from the 2024 ADA Conferencearticle image
Nuzhat (Kisat) Chalisa, MD, FACE, DABOM Link to Nuzhat (Kisat) Chalisa, MD, FACE, DABOM's page

GLP-1 in the Spotlight: Key Takeaways from the 2024 ADA Conference

Nuzhat (Kisat) Chalisa, MD, FACE, DABOM

Jul 1, 2024 Link to GLP-1 in the Spotlight: Key Takeaways from the 2024 ADA Conference